News for Waters Corporation (WATC34.SA)

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

Bernstein analyst Eve Burstein has revised the price target for Waters Corporation (WAT), lowering it from $430 to $400 while maintaining an Outperform rating f

Bank of America has revised its price target for Waters Corporation (WAT), reducing it from $410 to $350 while maintaining a Neutral rating on the stock. The ad

Barclays analyst Luke Sergott has revised the price target for Waters Corporation (WAT), reducing it from $400 to $350. The adjustment comes ahead of the first-

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireMILFORD, Mass., March 7, 2025 MILFORD, Mass., March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D., Wate

Waters Corp's robust R&D investment and global presence underpin its market leadership.Dependence on the biopharmaceutical sector and geopolitical risks presen

We recently published a list of 12 Best Scientific Instruments Stocks to Buy Right Now.

Waters delivers strong Q4'24 results, driven by academia and pharma growth. Learn about WAT stock's 2025 projections, emerging markets, and valuation challenges.

Feb 12, 2025 / 01:00PM GMTOperator Welcome to the Waters Cooperation fourth-quarter 2024 financial results conference call. (Operator Instructions) This call is

Shares of Waters Corporation (WAT) dropped 7.4% today following the company's announcement of its fourth-quarter results, which did not meet market expectations

Waters Corporation (NYSE:WAT) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ETCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit...

The following slide deck was published by Waters Corporation in conjunction with their 2024 Q4 earnings call.

Quarterly Revenue: $873 million, surpassing the estimated $857.21 million and growing 6% year-over-year.Quarterly GAAP EPS: $3.88, slightly below the estimated

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO),

Waters Corporation provides analytical workflow solutions across the healthcare and related space. Check out why WAT stock is an avoid at these trading levels.

PR NewswireMILFORD, Mass., Jan. 17, 2025 MILFORD, Mass., Jan. 17, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2024 financial result

PR NewswireMILFORD, Mass., Jan. 10, 2025 MILFORD, Mass., Jan. 10, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that it will host an Investo

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.